Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis 1 and 2 (NF1 and NF2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableActive Not RecruitingNCT04759781
What this trial is testing

MElanoma Research Lymph Node Prediction Implementation National_001

Who this might be right for
Melanoma
SkylineDx 1,820
Testing effectiveness (Phase 2)Ended earlyNCT00911248
What this trial is testing

PTC299 for Treatment of Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis 2
PTC Therapeutics 11
Not applicableStudy completedNCT07420751
What this trial is testing

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Who this might be right for
NF2-related Schwannomatosis
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00973739
What this trial is testing

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular Schwannoma
NYU Langone Health 21
Not applicableStudy completedNCT03617276
What this trial is testing

Reliability of Functional Outcome Measures in Neurofibromatosis 2

Who this might be right for
Neurofibromatosis 2
Guy's and St Thomas' NHS Foundation Trust 30
Testing effectiveness (Phase 2)Study completedNCT02104323
What this trial is testing

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Beijing Tiantan Hospital 20
Early research (Phase 1)Study completedNCT00030043
What this trial is testing

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

Who this might be right for
Neurofibromatosis 2
FDA Office of Orphan Products Development 10
Testing effectiveness (Phase 2)Study completedNCT01767792
What this trial is testing

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Progressive Vestibular Schwannomas
University of Alabama at Birmingham 22
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03079999
What this trial is testing

Study of Aspirin in Patients With Vestibular Schwannoma

Who this might be right for
Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2
Massachusetts Eye and Ear Infirmary 97
Not applicableLooking for participantsNCT01885767
What this trial is testing

Neurofibromatosis (NF) Registry Portal

Who this might be right for
Neurofibromatosis 1Neurofibromatosis 2Schwannomatosis
The Children's Tumor Foundation 20,000
Testing effectiveness (Phase 2)Ended earlyNCT01345136
What this trial is testing

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Who this might be right for
Neurofibromatosis Type 2Neuroma, Acoustic
Jonsson Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707947
What this trial is testing

Selumetinib for NF2-Related Schwannomatosis

Who this might be right for
Neurofibromatosis Type 2NF2NF2-related Schwannomatosis+3 more
Beijing Tiantan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02129647
What this trial is testing

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Vestibular Schwannomas
NYU Langone Health 13